Centro Investigación en Educación Superior

Recombinant and epitope-based vaccines on the road to the market and implications for vaccine design and production

AUTOR(ES): Patricio Oyarzún / Bostjan Kobe.
Licencia Creative Commons Reconocimiento CC BY. Esta obra está bajo una Licencia Creative Commons Reconocimiento CC BY 4.0 Internacional.

Novel vaccination approaches based on rational design of B- and T-cell epitopes – epitope-based vaccines – are making progress in the clinical trial pipeline. The epitope-focused recombinant protein-based malaria vaccine (termed RTS,S) is a next-generation approach that successfully reached phase-III trials, and will potentially become the first commercial vaccine against a human parasitic disease. Progress made on methods such as recombinant DNA technology, advanced cell-culture techniques, immunoinformatics and rational design of immunogens are driving the development of these novel concepts. Synthetic recombinant proteins comprising both B- and T-cell epitopes can be efficiently produced through modern biotechnology and bioprocessing methods, and can enable the induction of large repertoires of immune specificities. In particular, the inclusion of appropriate CD4+ T-cell epitopes is increasingly considered a key vaccine component to elicit robust immune responses, as suggested by results coming from HIV-1 clinical trials. In silico strategies for vaccine design are under active development to address genetic variation in pathogens and several broadly protective “universal” influenza and HIV-1 vaccines are currently at different stages of clinical trials. Other methods focus on improving population coverage in target populations by rationally considering specificity and prevalence of the HLA proteins, though a proof-of-concept in humans has not been demonstrated yet. Overall, we expect immunoinformatics and bioprocessing methods to become a central part of the next-generation epitope-based vaccine development and production process.

Documentos relacionados

Centro Investigación en Educación Superior

Computer-aided design of T-cell epitope-based vaccines: addressing population coverage

Epitope-based vaccines (EVs) make use of short antigen-derived peptides corresponding to immune epitopes, which are administered to trigger a protective humoral and/or […]

Centro Investigación en Educación Superior

A bioinformatics tool for epitope-based vaccine design that accounts for human ethnic diversity: Application to emerging infectious diseases

Background: Peptide vaccination based on multiple T-cell epitopes can be used to target well-defined ethnic populations. Because the response to […]

Centro Investigación en Educación Superior

Growth Factors and Astrocytes Metabolism: Possible Roles for Platelet Derived Growth Factor

Astrocytes exert multiple functions in the brain such as the development of blood–brain barrier characteristics, the promotion of neurovascular coupling, […]

Saltar a la barra de herramientas